Cannabinoids to Treat Serious Neurological and Inflammatory Conditions
Related Articles
Yield Growth (OTC: BOSQF) Files PCT Patent for Cannabis Root Extraction Method for Key Ingredient in 150 Proprietary Beauty and Wellness Formulas
April 17, 2019
admin
Newsmakers
Comments Off on Yield Growth (OTC: BOSQF) Files PCT Patent for Cannabis Root Extraction Method for Key Ingredient in 150 Proprietary Beauty and Wellness Formulas
VANCOUVER, British Columbia, April 16, 2019 — The Yield Growth Corp. CSE: BOSS) (OTC: BOSQF) (frankfurt:YG3) announces it has filed a patent application to protect its inventions for hemp root oil production and its use in […]
MGC Pharmaceuticals, LTD. (ASX: MXC) (OTC: MGCLF) Cannabis-based pharmaceuticals for major markets (revenue positive)
May 29, 2019
admin
CEO Interview, Healthcare
Comments Off on MGC Pharmaceuticals, LTD. (ASX: MXC) (OTC: MGCLF) Cannabis-based pharmaceuticals for major markets (revenue positive)
MGC Pharmaceuticals, LTD. (ASX: MXC) (OTC: MGCLF) CEO Interview with Roby Zomer, discussing the company’s vertically integrated “Seed-to Pharmacy” strategy, and product pipeline. The company has three […]
American Premium Water Corp (OTC: HIPH) Building CBD-infused consumer brand portfolio
April 5, 2019
admin
CEO Interview, Consumer
Comments Off on American Premium Water Corp (OTC: HIPH) Building CBD-infused consumer brand portfolio
American Premium Water Corp (OTC: HIPH) interview with CEO, Ryan Fishoff discussing the company’s growth strategy in building a portfolio of CBD-infused consumer brands, including beverages and topicals. Topics discussed […]